Ganirelix acetate是一种注射用促性腺激素释放激素 (GnRH) 拮抗剂，通过竞争性抑制GnRH受体，迅速降低雌二醇水平。该化合物可用于卵巢过度刺激综合征（OHSS）的研究，常用于生殖医学中以控制排卵。

Fluorogestone acetate是一种黄体酮化合物。Fluorogestone acetate 通过抑制脑下垂体黄体生成素 (LH) 的释放来抑制牛的排卵和同步发情周期。

Linzagolix（KLH-2109; OBE-2109）是一种有效的、非肽类、口服活性的GnRH拮抗剂，用于子宫肌瘤、子宫内膜异位症和子宫腺肌症的研究。

Cetrorelix acetate is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with IC50 of 1.21 nM.

Degarelix is a gonadotrophin-releasing hormone (GnRH) antagonist for the first-line treatment of androgen-dependent advanced prostate cancer.

Relugolix is a non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum. It possesses higher affinity and potent antagonistic activity compared with TAK-013.

Lecirelin is a synthetic GnRH analogue which showed a great efficacy in the treatment of bovine ovarian follicular cysts.

Elagolix sodium is an antagonist of human GnRH receptor (GnRHR) with IC50 and Ki of 0.25 nM and 3.7 nM, respectively.